Acadia Healthcare (ACHC) – Investment Analysts’ Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for Acadia Healthcare (NASDAQ: ACHC):

• 1/10/2025 – Acadia Healthcare had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $64.00 price target on the stock.
• 1/7/2025 – Acadia Healthcare was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $70.00 price target on the stock.
• 1/7/2025 – Acadia Healthcare had its price target lowered by analysts at TD Cowen from $70.00 to $66.00. They now have a “buy” rating on the stock.
• 1/6/2025 – Acadia Healthcare was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 12/19/2024 – Acadia Healthcare was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating.
• 12/12/2024 – Acadia Healthcare was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating. They now have a $75.00 price target on the stock, up previously from $45.00.
• 12/10/2024 – Acadia Healthcare had its “neutral” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $52.00 price target on the stock.
• 11/22/2024 – Acadia Healthcare was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 11/22/2024 – Acadia Healthcare had its price target lowered by analysts at Barclays PLC from $76.00 to $43.00. They now have an “overweight” rating on the stock.
• 11/18/2024 – Acadia Healthcare had its price target lowered by analysts at Royal Bank of Canada from $94.00 to $64.00. They now have an “outperform” rating on the stock.
• 11/14/2024 – Acadia Healthcare was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating.

Acadia Healthcare Stock Up 1.7 %

Shares of Acadia Healthcare stock traded up $0.77 on Monday, hitting $45.69. The company had a trading volume of 1,305,481 shares, compared to its average volume of 2,153,111. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market capitalization of $4.24 billion, a price-to-earnings ratio of 14.98, a P/E/G ratio of 1.77 and a beta of 1.29. The stock has a 50 day moving average of $40.54 and a 200-day moving average of $57.89. Acadia Healthcare Company, Inc. has a 1 year low of $36.50 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period last year, the business posted $0.91 earnings per share. Acadia Healthcare’s revenue was up 8.7% on a year-over-year basis. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the stock. State Street Corp boosted its holdings in shares of Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after acquiring an additional 95,613 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after acquiring an additional 454,044 shares during the period. LMR Partners LLP purchased a new stake in shares of Acadia Healthcare in the third quarter worth $1,616,000. Principal Financial Group Inc. raised its position in shares of Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after buying an additional 13,368 shares in the last quarter. Finally, Sivik Global Healthcare LLC raised its position in shares of Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after buying an additional 34,997 shares in the last quarter.

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.